Kapil Suchal

Dr. Kapil Suchal

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KSKapil Suchal
Kapil Suchal
SMSalma Malik
Salma Malik
SKSana Khan
Sana Khan
RKRajiv Rajiv Kumar
Rajiv Rajiv Kumar
SGSameer Goyal
Sameer Goyal
DADharamveer Singh Arya
Dharamveer Singh Arya
There is growing evidence that chronic hyperglycemia leads to the formation of advanced glycation end products (AGEs) which exerts its effect via interaction with the receptor for advanced glycation end products (RAGE). AGE-RAGE activation results in oxidative stress and inflammation. It is well known that this mechanism is involved in the pathogenesis of cardiovascular disease in diabetes. Kaempferol, a dietary flavonoid, is known to possess antioxidant, anti-apoptotic, and anti-inflammatory activities. However, little is known about the effect of kaempferol on myocardial ischemia-reperfusion (IR) injury in diabetic rats. Diabetes was induced in male albino Wistar rats using streptozotocin (70 mg/kg; i.p.), and rats with glucose level >250 mg/dL were considered as diabetic. Diabetic rats were treated with vehicle (2 mL/kg; i.p.) and kaempferol (20 mg/kg; i.p.) daily for a period of 28 days and on the 28th day, ischemia was produced by one-stage ligation of the left anterior descending coronary artery for 45 min followed by reperfusion for 60 min. After completion of surgery, rats were sacrificed and the heart tissue was processed for biochemical, morphological, and molecular studies. Kaempferol pretreatment significantly reduced hyperglycemia, maintained hemodynamic function, suppressed AGE-RAGE axis activation, normalized oxidative stress, and preserved morphological alterations. In addition, there was decreased level of inflammatory markers (tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and NF-κB), inhibition of active c-Jun N-terminal kinase (JNK) and p38 proteins, and activation of Extracellular signal regulated kinase 1/2 (ERK1/2) a prosurvival kinase. Furthermore, it also attenuated apoptosis by reducing the expression of pro-apoptotic proteins (Bax and Caspase-3), Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive cells, and increasing the level of anti-apoptotic protein (Bcl-2). In conclusion, kaempferol attenuated myocardial ischemia-reperfusion injury in diabetic rats by reducing AGE-RAGE/ mitogen activated protein kinase (MAPK) induced oxidative stress and inflammation.

Verified
Journal Article
Open access
PDF file
UMUmesh Mahajan
Umesh Mahajan
GCGovind Chandrayan
Govind Chandrayan
CPChandragouda R. Patil
Chandragouda R. Patil
DADharamveer Singh Arya
Dharamveer Singh Arya
KSKapil Suchal
Kapil Suchal
SGSameer Goyal
Sameer Goyal
We substantiated the role of peroxisome proliferator-activated receptor-γ (PPAR-γ) activation in the protective effect of apigenin against the myocardial infarction (MI) in diabetic rats. Diabetes was induced by intraperitoneal administration of a single dose of streptozotocin (55 mg/kg). The study groups included diabetic rats receiving vehicle, apigenin (75 mg/kg/day, orally), GW9662 (1 mg/kg/day, intraperitoneally), and a combination of apigenin and GW9662 for 14 days. The MI was induced in all the study groups except the diabetic control group by subcutaneous injection of 100 mg/kg/day of isoproterenol on the two terminal days. The diabetes and isoproterenol-induced MI was evident as a reduction in the maximal positive and negative rate of developed left ventricular pressure and an increase in the left ventricular end-diastolic pressure. The activities of creatine kinase on myocardial bundle (CK-MB) and lactate dehydrogenase (LDH) were also reduced. Apigenin treatment prevented the hemodynamic perturbations, restored the left ventricular function and reinstated a balanced redox status. It protected rats against an MI by attenuating myonecrosis, edema, cell death, and oxidative stress. GW9662, a PPAR-γ antagonist reversed the myocardial protection conferred by apigenin. Further, an increase in the PPAR-γ expression in the myocardium of the rats receiving apigenin reinforces the role of PPAR-γ pathway activation in the cardioprotective effects of apigenin.

1 October 2018 in Journal Of Hypertension
Verified
Journal Article
Closed access
DADharam Vir Arya
Dharam Vir Arya
SASalma M. Alik
Salma M. Alik
KSKapil Suchal
Kapil Suchal
JBJagriti Bhatia
Jagriti Bhatia
Diabetes mellitus is a major metabolic disorder characterized by hyperglycemia resulting from defective insulin secretion and/or response. Diabetic nephropathy is one of the major micro-vascular complications of Diabetes mellitus which results due to inflammatory phenomenon, fibrosis and oxidative stresses. Apigenin (4’,5, 7-trihydroxyflavone), a plant derived flavonoid possess anti-inflammatory, anti-fibrotic and anti-diabetic properties was used to evaluate its effect in streptozotocin induced diabetic rats to scrutinize its efficacy in halting the progression of diabetic nephropathy. Male Wistar rats were divided into 5 groups (n = 8) i.e. I (normal), II (diabetes- control), III (Apigenin 20 mg/kg i.p.), IV (Ramipril 2 mg/kg p.o.) and V (Apigenin 20 mg/kg per se) for a duration of 8 months. All groups were administered single injection of STZ (55 mg/kg i.p.) to induce diabetic mellitus. Different parameters were used for confirmation of their effect. Apigenin (20 mg/kg) on treatment was observed to attenuate oxidative stress, renal dysfunction and fibrosis (decreased fibronectine, TGF-β1 and type IV collagen) in diabetic rats. Histopathological studies demonstrated reduction in collagen deposition, inflammation and glomerulosclerosis in renal tissue of rats. Also Apigenin suppressed inflammation by inhibiting MAPK activation and decrease apoptosis. All changes were comparable to the ramipril group. This study substantiated the beneficial effect of Apigenin by virtue of anti-oxidative, anti-inflammatory and anti-apoptotic properties. Hence, Apigenin imparts diabetic nephropathy induced by streptozotocin.

1 September 2016 in Journal Of Hypertension
Verified
Journal Article
Closed access
PDF file
KSKapil Suchal
Kapil Suchal
SMSalma Malik
Salma Malik
JBJagriti Bhatia
Jagriti Bhatia
DADharamveer Singh Arya
Dharamveer Singh Arya
There is substantial data suggest that hyperglycemia induce AGE-RAGE activation. Increased AGE-RAGE axis results in oxidative stress and inflammation which acts as a causative factor in the development of cardiovascular disease in the diabetics. Kaempferol, a dietary flavonoid, has shown to possess antioxidant, anti-inflammatory and anti-apoptotic properties. Thus, this study was undertaken to evaluate the effect of kaempferol in myocardial ischemia-reperfusion (IR) injury in diabetic rats. There is substantial data suggest that hyperglycemia induce AGE-RAGE activation. Increased AGE-RAGE axis results in oxidative stress and inflammation which acts as a causative factor in the development of cardiovascular disease in the diabetics. Kaempferol, a dietary flavonoid, has shown to possess antioxidant, anti-inflammatory and anti-apoptotic properties. Thus, this study was undertaken to evaluate the effect of kaempferol in myocardial ischemia-reperfusion (IR) injury in diabetic rats. A single injection of streptozotocin was injected to overnight fasted adult male albino Wistar rats to induce diabetes. Rats with fasting blood glucose level > 250 mg/dl were considered as diabetic and included in the study. Diabetic rats were administered vehicle (2 ml/kg; i.p.), kaempferol (20 mg/kg; i.p.) for 28 days. On 28th day, ischemia was produced by ligation of left anterior descending coronary artery for 45 min followed by reperfusion for 60 min. Kaempferol administration significantly improved cardiac function as evidenced by normalization of arterial pressure, ±LVdP/dt and LVEDP in diabetic rats. Kaempferol also reduced hyperglycemia, strengthen antioxidant defence system and preserved myocardial architecture. Furthermore, kaempferol significantly inhibited inflammation (decreased TNF-α, IL-6 and NF-κB level) and apoptosis (increased Bcl-2 and decreased Bax and Caspase-3 expressions). This improvement was due to the inhibition of AGE-RAGE and MAPK pathway in the diabetic rats. Thus, kaempferol significantly ameliorated ischemia-reperfusion induced myocardial injury in diabetic rats by reducing activation of AGE-RAGE axis which further inhibited oxidative stress and inflammation.

1 September 2016 in Journal Of Hypertension
Verified
Journal Article
Closed access
PDF file
DADharamveer Singh Arya
Dharamveer Singh Arya
KSKapil Suchal
Kapil Suchal
SMSalma Malik
Salma Malik
PBPoorva Bhargava
Poorva Bhargava
JBJagriti Bhatia
Jagriti Bhatia
The detrimental effects of restoration of coronary blood flow following an acute myocardial infarction is a major concern as reperfusion predisposes to myocardial injury. Kaempferol (KMP), a naturally occurring polyphenolic compound, present in tea, broccoli, propolis and grapefruit, possesses anti-oxidant, anti-inflammatory, anti-apoptotic, anti-cancer, neuroprotective, cardioprotective and anti-diabetic properties. Therefore in the present study, we aimed to investigate the effect of kaempferol in ischemia-reperfusion (IR) model of myocardial injury in rats. Male albino wistar rats were used for the study. They were divided into sham, IR-control, KMP-20+IR and KMP 20 per se groups. KMP was administered daily to the rats at a dose of 20 mg/kg intraperitoneally for a period of 15 days. On the 15th day, ischemia was produced by one-stage ligation of left anterior descending coronary artery for 45 minutes followed by reperfusion for 60 minutes. Rats were sacrificed after completion of surgery and the heart was excised and processed for biochemical, morphological and molecular studies. KMP pretreatment significantly attenuated IR injury by maintaining cardiac function, normalizing oxidative stress and preserving morphological alterations. Also, there was a decrease in the level of inflammatory markers (TNF-α, IL-6 and NFκB), inhibition of active JNK and p38 proteins and activation of ERK1/2, a pro-survival kinase. Furthermore, it also ameliorated apoptosis by reducing the expression of pro-apoptotic proteins (Bax and Caspase-3), TUNEL positive cells and increasing the level of anti-apoptotic proteins (Bcl-2). KMP protects against IR injury by attenuating inflammation and apoptosis through modulation of MAPK pathway and amelioration of the redox state of the myocardium.